Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Shares Issued (2020 - 2025)

Rapid Micro Biosystems' Shares Issued history spans 6 years, with the latest figure at $395000.0 for Q3 2025.

  • For Q3 2025, Shares Issued rose 71.0% year-over-year to $395000.0; the TTM value through Sep 2025 reached $485000.0, up 19.75%, while the annual FY2024 figure was $231000.0, 28.33% up from the prior year.
  • Shares Issued for Q3 2025 was $395000.0 at Rapid Micro Biosystems, up from -$206000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $523000.0 in Q1 2021 and bottomed at -$523000.0 in Q3 2021.
  • The 5-year median for Shares Issued is $171000.0 (2023), against an average of $133214.3.
  • The largest annual shift saw Shares Issued crashed 100.63% in 2023 before it soared 23200.0% in 2024.
  • A 5-year view of Shares Issued shows it stood at $403000.0 in 2021, then grew by 0.99% to $407000.0 in 2022, then tumbled by 57.25% to $174000.0 in 2023, then skyrocketed by 32.76% to $231000.0 in 2024, then skyrocketed by 71.0% to $395000.0 in 2025.
  • Per Business Quant, the three most recent readings for RPID's Shares Issued are $395000.0 (Q3 2025), -$206000.0 (Q2 2025), and $296000.0 (Q1 2025).